(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.71% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.98%.
Aptargroup's revenue in 2026 is $3,872,744,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $255,600,365,580, with the lowest ATR revenue forecast at $244,623,271,228, and the highest ATR revenue forecast at $267,598,584,988. On average, 10 Wall Street analysts forecast ATR's revenue for 2027 to be $268,109,147,516, with the lowest ATR revenue forecast at $256,110,928,108, and the highest ATR revenue forecast at $283,106,921,776.
In 2028, ATR is forecast to generate $285,340,632,836 in revenue, with the lowest revenue forecast at $274,235,897,852 and the highest revenue forecast at $298,487,617,932.